This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
Tagrisso plus chemotherapy achieves nearly four-year median overall survival in EGFR-mutated advanced lung cancer, setting new global standard in phase III trial
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Under an exclusive distribution agreement, Sartorius Stedim Biotech will offer Nanotein’s lead products globally
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
IGI partners with AbbVie and grants exclusive rights to globally develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China
Xtandi is approved in over 80 countries, including the U.S., EU, and Japan
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
Subscribe To Our Newsletter & Stay Updated
